Target intelligence / Profile preview

TM4SF19-DYNLT2B readthrough (TM4SF19-DYNLT2B)

Target
TM4SF19-DYNLT2B
Molecular classification
Non-coding RNA (ncRNA), Read-through transcript, Nonsense-mediated decay candidate
01

Overview

TM4SF19-DYNLT2B is a naturally occurring read-through transcript between TM4SF19 and DYNLT2B on chromosome 3, generally subject to nonsense-mediated mRNA decay and is not expected to produce a protein product. No biological function or disease involvement as a protein or target has been demonstrated. Occasionally, rare associations with specific rare syndromes may arise through linked genetic variation, but this transcript itself is not an actionable target for drugs or diagnostics[1][9].

Other names
TM4SF19-TCTEX1D2
02

Mechanism of action

None (not a drug target)

03

Biological functions

None clearly identified; the transcript is generally degraded and does not encode a protein
04

Disease associations

Associated with Short-Rib Thoracic Dysplasia 17 With Or Without Polydactyly (as per linked gene associations)
05

Safety considerations

None relevant (not a therapeutic target)
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on TM4SF19-DYNLT2B readthrough (TM4SF19-DYNLT2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TM4SF19-DYNLT2B readthrough (TM4SF19-DYNLT2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call